(+)-Agelasine D: Improved synthesis and evaluation of antibacterial and cytotoxic activities

Journal of Natural Products

Volumn 69, Issue 3, 2006, Pages 381-386

  Vik, Anders ^a   Hedner, Erik ^b   Charnock, Colin ^c   Samuelsen, Ørjan ^d   Larsson, Rolf ^e   Gundersen, Lise Lotte ^a   Bohlin, Lars ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b UPPSALA UNIVERSITY   (Sweden)

^c OSLO METROPOLITAN UNIVERSITY   (Norway)

^d UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^e UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AGELASINE D; ANTIINFECTIVE AGENT; N 6 TERT BUTOXYAGELASINE D; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SPONGE (PORIFERA);

ANIMALS; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; DITERPENES; DRUG RESISTANCE, MULTIPLE; DRUG SCREENING ASSAYS, ANTITUMOR; MICE; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; PORIFERA; PURINES; STEREOISOMERISM; TUMOR CELLS, CULTURED;

AGELAS; ANIMALIA; MYCOBACTERIUM TUBERCULOSIS; NEGIBACTERIA; PORIFERA; POSIBACTERIA;

EID: 33645988178     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np050424c     Document Type: Article

References (39)

1. (a) Blunt, J. W.; Copp, B. R.; Munro, M. H. G.; Northcode, P.; Prinsep, M. R. Nat. Prod. Rep. 2004, 21, 1-49.
2. (b) Hill, R. A. Annu. Rep. Prog. Chem., Sect. B 2004, 100, 169-189.
3. (c) Donia, M.; Hamann, M. T. Lancet Infect. Dis. 2003, 3, 338-348.
4. (d) Capon, R. J. Eur. J. Org. Chem. 2001, 633-645, and references therein.
5. (a) Nakamura, H.; Wu, H.; Ohizumi, Y.; Hirata, Y. Tetrahedron Lett. 1984, 25, 2989-2992.
6. (b) Wu, H.; Nakamura, H.; Kobayashi, J.; Ohizumi, Y. Tetrahedron Lett. 1984, 25, 3719-3722.
7. (c) Capon, R. J.; Faulkner, D. J. J. Am. Chem. Soc. 1984, 106, 1819-1822.
8. (d) Wu, H.; Nakamura, H.; Kobayashi, J.; Kobayashi, M.; Ohizumi, Y.; Hirata, Y. Bull. Chem. Soc. Jpn. 1986, 59, 2495-2504.
9. (e) Hattori, T.; Adachi, K.; Shizuri, Y. J. Nat. Prod. 1997, 60, 411-413.
10. (f) Fu, X.; Schmitz, F. J.; Tanner, R. S.; Kelly-Borges, M. J. Nat. Prod. 1998, 61, 548-550.
11. (g) Iwagawa, T.; Kaneko, M.; Okamura, H.; Nakatani, M.; van Soest, R. W. M. J. Nat. Prod. 1998, 61, 1310-1312.
12. Piers, E.; Livain, M. L.; Han, Y.; Plourde, G. L.; Guy, L.; Yen, W.-L. J. Chem. Soc., Perkin Trans. 1 1995, 963-966.
13. (a) Piers, E.; Roberge, Y. R. Tetrahedron Lett. 1992, 33, 6923-6926.
14. (b) Iio, H.; Asao, K.; Tokoroyama, T. J. Chem. Soc., Chem. Commun. 1985, 774-775.
15. Utenova, B. T.; Gundersen, L.-L. Tetrahedron Lett. 2004, 45, 4233-4235.
16. Bakkestuen, A. K.; Gundersen, L.-L.; Petersen, P.; Utenova, B. T.; Vik, A. Org. Biol. Chem. 2005, 3, 1025-1033.
17. Asao, K.; Iio, H.; Tokoroyama, T. Tetrahedron Lett. 1989, 30, 6401-6404.
18. Alvarez-Manzaneda, E. J.; Chahboun, R.; Torres, E. C.; Alvarez, E.; Alvarez-Manzaneda, R.; Haidour, A.; Ramos Lopes, J. M. Tetrahedron Lett. 2005, 46, 3755-3759.
19. For other syntheses of (+)-copalol, see for instance: (a) Toshima, H.; Oikawa, H.; Toyomasu, T.; Sassa, T. Tetrahedron 2000, 56, 8443-8450.
20. (b) Yee, N. K. N.; Coates, R. M. J. Org. Chem. 1992, 57, 4598-4608.
21. Fujii, T.; Itaya, T. Heterocycles 1999, 51, 393-454, and references therein.
22. Maki, Y.; Kameyama, K.; Suzuki, M.; Sako, M.; Hirota, K. J. Chem. Res. (M) 1984, 3609-3610.
23. Mangalindan, G. C.; Talaue, M. T.; Cruz, L. J.; Franzblau, S. G.; Adams, L. B.; Richardson, D.; Ireland, C. M.; Conception, G. P. Planta Med. 2000, 66, 364-365.
24. Nakano, V.; Avila-Campos, M. J. Mem. Inst. Oswaldo Cruz, Rio de Janeiro 2004, 99, 319-324.
25. Chaudhry, R.; Mathur, P.; Dhawan, B.; Kumar, L. Emerg. Infect. Dis. 2001, 7, 485-486.
26. Ishida, K.; Ishibashi, M.; Shigemori, H.; Sasaki, T.; Kobayashi, J. Chem. Pharm. Bull. 1992, 40, 766-767.
27. An, J.; Fisher, M.; Retting, M. B. Oncogene 2005, 24, 1563-1570, and references therein.
28. Okamoto, M.; Hara, I.; Miyakea, H.; Hara, S.; Gotoha, A.; Arakawa, A.; Kamidono, S. Urology 2001, 57, 188-192.
29. See for instance: Brown, E. D.; Wright, G. D. Chem. Rev. 2005, 105, 759-774.
30. Palandoken, H.; Bocian, C. M.; McCombs, M. R.; Nantz, M. H. Tetrahedron Lett. 2005, 46, 6667-6669.
31. Chimiak, A. K. T. Rocz. Chem. 1974, 48, 139-142.
32. Buchi, G.; Biermann, K. Croat. Chem. Acta 1957, 29, 163-171.
33. Carman, R. M.; Duffield, A. R. Aust. J. Chem. 1995, 48, 1357-1366.
34. Itaya, T.; Saito, T.; Kawakatsu, S.; Fujii, T. Chem. Pharm. Bull. 1975, 23, 2643-2653.
35. Fujii, T.; Saito, T.; Sakuma, T.; Minami, M.; Inoue, I. Heterocycles 1981, 16, 215-219.
36. Vorland, L. H.; Ulvatne, H. M.; Andersen, J.; Haukland, H.; Rekdal, Ø.; Svendsen, J. S.; Gutteberg, T. Scand. J. Infect. Dis. 1998, 30, 513-517.
37. National Committee for Clinical Laboratory Standards. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria, 3rd ed.; approved standard, NCCLS, Villanova, PA, 1993; p 9085.
38. (a) Larsson, R.; Nygren, P. Anticancer Res. 1989, 9, 1111-1119.
39. (b) Dhar, S.; Nygren, P.; Csoka, K.; Botling, J.; Nilsson, K.; Larsson, R.; Huang, H. Br. J. Cancer 1996, 74, 888-896.